NAPPA-Based Vaccines for a New Proteogenomics Approach for Public Health
Journal Title: NanoWorld Journal - Year 2015, Vol 1, Issue 1
Abstract
Vaccinology was developed for the first time in 1796 when Jenner empirically implemented a vaccine against smallpox using animal-to-human cowpox inoculation. Since then, it has become a very complex science due to the merging of disciplines ranging from structural and functional, cellular and molecular biology and immunology to bioinformatics and nanobiotechnology, as well as systems biology and synthetic biology and engineering. In the frame of evidence-based medicine (EBM), evidence-based vaccinology emerged as an important sub-field: vaccinology has nowadays become more and more predictive and personalized. With the discovery that many patients with cancer develop antibodies against p53 (the so-called oncoantibodies), it was evident that oncoprotein are immunogenic and can be used for immunotherapeutics purposes. In this manuscript, we report Nucleic Acid Programmable Protein Arrays (NAPPA)-based Quartz Crystal Microbalance (QCM) measurement of p53 immunogenicity and kinetics, in the perspective of developing an effective p53 therapy. NAPPA-based QCM_D can be a useful platform for proving the immunogenicity of oncoprotein-based vaccines. Recently, the field of vaccinology has extended from vaccines for infectious diseases to vaccines not only preventive but also therapeutic for chronic-degenerative diseases such as cancer. Peptide-based immunotherapeutics has been proven to be quite effective for cancer treatment and NAPPA-based QCM_D has the promise of providing clinicians with quick, rapid and cheap measurement of oncoprotein kinetics and bindings with immune cells. Moreover, it can be a precious tool for implementing personalized and predictive vaccinology.
Authors and Affiliations
Nicola Luigi Bragazzi, Eugenia Pechkova, Claudio Nicolini
High Efficiency Preparation, Structure and Properties of Silicon Nano-Crystals by Induction Plasma Method
Free-standing silicon nano-crystals were synthesized from silicon multicrystals with high efficiency by induction plasma method. The particle morphology and distribution of nano powder were significantly influenced by po...
Proceedings of the First NanoWorld Conference in Boston (NWC-2016). Part II: Plenary Symposia
Regimen-related toxicities are common, often painful, disruptive and dose-limiting complications of many forms of chemo- and radiation therapy used for the treatment of cancer. In addition to their symptomatic and physio...
Proceedings of the 2nd NanoWorld Conference in Boston (NWC-2017). Part VI: Conclusions of World Peace Forum and of NWC 2017
In the last few years the problems of humanity are growing in all sectors of the economy, from energy to environment and disasters induced by nuclear reactors, from cancer to hardware and space such as asteroids. More th...
Science and Technology for A Sustainable Human Development
At the end of the NanoWorld Conference in San Francisco 25 April 2018 it was decided to formalize the move of the NanoWorld Journal Headquarter from Texas (USA) at United Scientific Group to Bergamo (Europe) at Fondazion...
Strategist PLGA Nano-capsules to Deliver siRNA for Inhibition of Carcinoma and Neuroblastoma Cell Lines by Knockdown of MYC Proto-oncogene using CPPs and PNA
RNA interference and the therapeutic applications using small interfering RNA was discovered more than 10 years ago and currently is used in various applications including in therapeutic field. However the research in th...